Schwendeman A - Search Results

1

Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice.

He H, Adili R, Liu L, Hong K, Holinstat M, Schwendeman A. He H, et al. Among authors: schwendeman a. Sci Adv. 2020 Dec 4;6(49):eabd0130. doi: 10.1126/sciadv.abd0130. Print 2020 Dec. Sci Adv. 2020. PMID: 33277254 Free PMC article.

2

Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.

Subramanian C, Kuai R, Zhu Q, White P, Moon JJ, Schwendeman A, Cohen MS. Subramanian C, et al. Among authors: schwendeman a. Surgery. 2016 Jan;159(1):284-94. doi: 10.1016/j.surg.2015.08.023. Epub 2015 Nov 12. Surgery. 2016. PMID: 26582501 Free PMC article.

3

High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Kuai R, Li D, Chen YE, Moon JJ, Schwendeman A. Kuai R, et al. Among authors: schwendeman a. ACS Nano. 2016 Mar 22;10(3):3015-41. doi: 10.1021/acsnano.5b07522. Epub 2016 Feb 25. ACS Nano. 2016. PMID: 26889958 Free PMC article. Review.

4

Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.

Yuan Y, Wen J, Tang J, Kan Q, Ackermann R, Olsen K, Schwendeman A. Yuan Y, et al. Among authors: schwendeman a. Int J Nanomedicine. 2016 Nov 22;11:6229-6238. doi: 10.2147/IJN.S112835. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27920529 Free PMC article.

5

Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.

Tang J, Kuai R, Yuan W, Drake L, Moon JJ, Schwendeman A. Tang J, et al. Among authors: schwendeman a. Nanomedicine. 2017 Aug;13(6):1869-1878. doi: 10.1016/j.nano.2017.04.009. Epub 2017 Apr 18. Nanomedicine. 2017. PMID: 28434931 Free PMC article.

6

Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.

Kuai R, Subramanian C, White PT, Timmermann BN, Moon JJ, Cohen MS, Schwendeman A. Kuai R, et al. Among authors: schwendeman a. Int J Nanomedicine. 2017 Sep 6;12:6581-6594. doi: 10.2147/IJN.S140591. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28919755 Free PMC article.

7

Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.

Guo Y, Yuan W, Yu B, Kuai R, Hu W, Morin EE, Garcia-Barrio MT, Zhang J, Moon JJ, Schwendeman A, Eugene Chen Y. Guo Y, et al. Among authors: schwendeman a. EBioMedicine. 2018 Feb;28:225-233. doi: 10.1016/j.ebiom.2017.12.021. Epub 2017 Dec 20. EBioMedicine. 2018. PMID: 29361501 Free PMC article.

8

Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.

Kuai R, Yuan W, Son S, Nam J, Xu Y, Fan Y, Schwendeman A, Moon JJ. Kuai R, et al. Among authors: schwendeman a. Sci Adv. 2018 Apr 18;4(4):eaao1736. doi: 10.1126/sciadv.aao1736. eCollection 2018 Apr. Sci Adv. 2018. PMID: 29675465 Free PMC article.

9

Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.

He H, Liu L, Morin EE, Liu M, Schwendeman A. He H, et al. Among authors: schwendeman a. Acc Chem Res. 2019 Sep 17;52(9):2445-2461. doi: 10.1021/acs.accounts.9b00228. Epub 2019 Aug 19. Acc Chem Res. 2019. PMID: 31424909 Review.

10

Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.

Fawaz MV, Kim SY, Li D, Ming R, Xia Z, Olsen K, Pogozheva ID, Tesmer JJG, Schwendeman A. Fawaz MV, et al. Among authors: schwendeman a. J Pharmacol Exp Ther. 2020 Feb;372(2):193-204. doi: 10.1124/jpet.119.257568. Epub 2019 Nov 27. J Pharmacol Exp Ther. 2020. PMID: 31776208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters